TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T-cell epitope: Evidence for further processing in the endoplasmic reticulum

Melanoma Research

Volumn 8, Issue 4, 1998, Pages 345-353

  Wang, Y ^a   Guttoh, D S ^a   Androlewicz, M J ^a  

^a NONE

Author keywords

Antigen processing; Melanoma; Peptide transport; TAP

Indexed keywords

EPITOPE; MONOPHENOL MONOOXYGENASE;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN PROCESSING;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BURKITT LYMPHOMA; ENDOPLASMIC RETICULUM; EPITOPES; HUMANS; MICROSOMES; MOLECULAR WEIGHT; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0031712702     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199808000-00008     Document Type: Article

References (34)

1. Lehner PJ, Cresswell P. Processing and delivery of peptides presented by MHC class I molecules. Curr Opin Immunol 1996; 8: 59-67.
2. Williams DB, Vassilakos A, Suh W-K. Peptide presentation by MHC class I molecules. Trends Cell Biol 1996; 6: 267-273.
3. Hilt W, Wolf DH. Proteasomes: destruction as a programme. Trends Biochem Sci 1996; 21: 96-102.
4. Tanaka K, Tanahashi N, Tsurumi C, et al. Proteasomes and antigen processing. Adv Immunol 1997; 64: 1-38.
5. Spies T, Bresnahan M, Bahram S, et al. A gene in the human major histocompatibility complex MHC class II region controlling the MHC class I antigen presentation pathway. Nature 1990; 348: 744-747.
6. Trowsdale J, Hanson I, Mockridge I, et al. Sequences encoded in the MHC class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990; 348: 741-744.
7. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990; 253: 1723-1726.
8. Androlewicz MJ, Anderson KS, Cresswell P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex MHC class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci USA 1993; 90: 9130-9134.
9. Neefjes JJ, Momburg F, Hammerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993; 261: 769-771.
10. Shepherd JC, Schumacher TNM, Ashton-Rickard PG, et al. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 1993; 74: 577-584.
11. 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc Natl Acad Sci USA 1994; 91: 12716-12720.
12. Meyer TH, van Endert PM, Uebel S, et al. Functional expression and the purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett 1994; 351: 443-447.
13. Androlewicz MJ, Cresswell P. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1994; 1: 7-14.
14. Momburg F, Roelse J, Hammerling GJ, et al. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 1994; 179: 1613-1623.
15. van Endert PM, Riganelli D, Greco G, et al. The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 1995; 182: 1883-1895.
16. Wolfel T, Van Pel A, Bricard V, et al. Two tyrosinase nonapedptides recognised on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 1994; 24: 759-764.
17. Cox AL, Skipper J, Chen Y, et al. Identification of a peptide recognised by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264: 716-719.
18. Castelli C, Storkus WJ, Maeurer MJ, et al. Mass spectrometric identification of a naturally processed melanoma peptide recognised by CD8+ cytotoxic T lymphocytes. J Exp Med 1995; 181: 363-368.
19. Wang R-F, Robbins PF, Kawakami Y, et al. Identification of gene encoding a melanoma tumor antigen recognised by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med 1995; 181: 799-804.
20. Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176: 1453-1457.
21. Boel P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognised on human melanomas by cytolytic T lymphocytes. Immunity 1995; 2: 167-175.
22. Van den Eynde B, Peeters O, De Backer O, et al. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995; 182: 689-698.
23. Chang SA, Lacaille VG, Guttoh DS, et al. Binding and transport of melanoma-specific antigenic peptides by the transporter associated with antigen processing. Mol Immunol 1996; 33: 1165-1169.
24. Pulvertaft RJV. Cytology of Burkitt's tumour. Lancet 1964; i: 238-240.
25. Roche PA, Cresswell P. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J Immunol 1990; 144: 1849-1856.
26. Heemels M-T, Ploegh HL. Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1994; 1: 775-784.
27. Skipper JCA, Hendrickson RC, Gulden PH, et al. An HLA-A2 restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 1996; 183: 527-534.
28. Halaban R, Cheng E, Zhang Y, et al. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc Natl Acad Sci USA 1997; 94: 6210-6215.
29. Hughes EA, Hammond C, Cresswell P. Misfolded major histocompatibility complex MHC class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci USA 1997; 94: 1896-1901.
30. Hiller MM, Finger A, Schweiger M, et al. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 1996; 273: 1725-1728.
31. Huppa JB, Ploegh HL. The α chain of the T cell antigen receptor is degraded in the cytosol. Immunity 1997; 7: 113-122.
32. Elliott T, Willis A, Cerundolo V, et al. Processing of major histocompatibility MHC class I-restricted antigens in the endoplasmic reticulum. J Exp Med 1995; 181: 1481-1491.
33. Snyder HL, Yewdell JW, Bennink JR. Trimming of antigenic peptides in an early secretory compartment. J Exp Med 1994; 180: 2389-2394.
34. Neisig, A, Roelse J, Sijts AJAM, et al. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J Immunol 1995; 154: 1273-1279.